INNV
InnovAge Holding Corp. NASDAQ Listed Mar 4, 2021$8.07
Mkt Cap $1.1B
52w Low $3.13
65.3% of range
52w High $10.69
50d MA $8.34
200d MA $5.97
P/E (TTM)
-37.8x
EV/EBITDA
159.5x
P/B
4.3x
Debt/Equity
0.4x
ROE
-2.5%
P/FCF
18.8x
RSI (14)
—
ATR (14)
—
Beta
0.50
50d MA
$8.34
200d MA
$5.97
Avg Volume
346.9K
InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities. It manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. The company offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management. It serves approximately 6,850 PACE participants in the United States; and operates 18 PACE centers in Colorado, California, New Mexico, Pennsylvania, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 2007 and is headquartered in Denver, Colorado.
8950 East Lowry Boulevard · Denver, CO 80230 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2026 | AMC | 0.06 | -0.22 | -466.7% | 7.96 | -3.9% | +2.0% | -0.5% | -6.3% | -2.8% | +2.6% | — |
| Feb 3, 2026 | AMC | 0.04 | 0.08 | +100.0% | 5.66 | +14.8% | +37.5% | -4.0% | +11.9% | +4.4% | -4.1% | — |
| Nov 4, 2025 | AMC | 0.01 | 0.06 | +500.0% | 4.84 | +0.2% | -17.6% | +22.3% | +8.4% | -4.5% | +7.3% | — |
| Sep 9, 2025 | AMC | -0.02 | -0.01 | +50.0% | 4.27 | +0.7% | -2.8% | +11.3% | -1.5% | +9.5% | +4.0% | — |
| May 6, 2025 | AMC | -0.02 | -0.08 | -300.0% | 2.85 | +0.0% | +14.4% | +9.5% | +2.0% | +4.4% | +4.2% | — |
| Feb 4, 2025 | AMC | -0.01 | -0.10 | -900.0% | 3.69 | -2.7% | -8.9% | -4.2% | +2.2% | +1.5% | +0.6% | — |
| Nov 5, 2024 | AMC | -0.04 | -0.04 | -5.3% | 6.07 | +3.8% | +3.8% | -3.8% | -1.0% | -0.5% | -3.9% | — |
| Sep 10, 2024 | AMC | -0.01 | -0.01 | -61.6% | 6.18 | +4.5% | -6.5% | +4.2% | -0.5% | -1.3% | +0.7% | — |
| May 7, 2024 | AMC | -0.03 | -0.04 | -16.6% | 4.26 | +3.3% | +0.0% | +1.6% | -5.8% | -5.6% | +4.4% | — |
| Feb 6, 2024 | AMC | -0.02 | -0.03 | -67.6% | 5.33 | +1.9% | -3.9% | +3.5% | +7.0% | +3.9% | -12.2% | — |
| Nov 7, 2023 | AMC | -0.04 | -0.08 | -112.1% | 5.50 | -1.3% | -2.0% | +1.1% | +1.8% | +1.6% | +11.2% | — |
| Sep 12, 2023 | AMC | -0.04 | -0.09 | -155.5% | 6.50 | -2.3% | -2.9% | +7.6% | +11.8% | -7.1% | -0.4% | — |
| May 9, 2023 | AMC | -0.05 | -0.05 | +0.0% | 6.21 | +2.1% | +0.6% | +0.6% | +0.5% | +1.3% | -1.1% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 23 | JP Morgan | Maintains | Underweight → Underweight | — | $8.16 | $8.31 | +1.8% | +9.3% | +0.0% | -0.2% | +4.5% | -3.7% |
| Dec 17 | JP Morgan | Downgrade | Neutral → Underweight | — | $4.40 | $4.28 | -2.7% | -7.3% | -8.1% | -5.9% | +18.7% | +0.7% |
| Mar 13 | JP Morgan | Maintains | Neutral → Neutral | — | $4.65 | $4.84 | +4.1% | +0.9% | -8.5% | +0.0% | +8.4% | +7.3% |
| Feb 8 | Goldman Sachs | Maintains | Neutral → Neutral | — | $5.12 | $5.18 | +1.2% | +3.5% | +7.0% | +3.9% | -12.2% | +4.3% |
| Feb 15 | Goldman Sachs | Maintains | Neutral → Neutral | — | $7.70 | $7.79 | +1.2% | -0.1% | +0.4% | -0.8% | -1.0% | +0.0% |
| Feb 8 | JP Morgan | Maintains | Neutral → Neutral | — | $7.50 | $7.81 | +4.1% | +1.9% | -0.4% | +0.8% | +0.0% | +0.4% |
| Nov 23 | Goldman Sachs | Maintains | Neutral → Neutral | — | $7.23 | $7.23 | +0.0% | -7.1% | +2.5% | -4.9% | -4.4% | +3.5% |
| Nov 16 | Citigroup | Maintains | Neutral → Neutral | — | $7.21 | $7.25 | +0.6% | +0.1% | +1.4% | +0.0% | -6.4% | +5.5% |
| Sep 15 | Barclays | Maintains | Equal Weight → Equal Weight | — | $4.94 | $4.93 | -0.2% | +3.6% | +8.0% | +13.0% | -1.3% | -1.3% |
| May 16 | Baird | Downgrade | Outperform → Neutral | — | $5.13 | $4.86 | -5.3% | -11.7% | +1.1% | +1.3% | -3.2% | -0.9% |
| May 11 | Piper Sandler | Maintains | Underweight → Underweight | — | $4.53 | $4.14 | -8.6% | +6.2% | -1.0% | +7.8% | -11.7% | +1.1% |
| Apr 20 | Piper Sandler | Downgrade | Neutral → Underweight | — | $6.59 | $6.29 | -4.6% | -10.8% | -6.3% | -9.4% | +12.6% | -10.9% |
| Dec 28 | Goldman Sachs | Downgrade | Buy → Neutral | — | $4.71 | $4.61 | -2.1% | -1.9% | +6.7% | +0.2% | +1.2% | +0.2% |
| Dec 27 | Barclays | Downgrade | Overweight → Equal Weight | — | $5.31 | $5.32 | +0.2% | -11.3% | -1.9% | +6.7% | +0.2% | +1.2% |
| Dec 17 | JP Morgan | Maintains | Neutral → Neutral | — | $7.73 | $7.83 | +1.3% | +5.7% | +0.0% | +1.6% | -0.6% | -35.6% |
| Sep 29 | Citigroup | Downgrade | Buy → Neutral | — | $6.78 | $6.61 | -2.5% | -5.5% | +3.1% | +2.4% | -3.4% | +5.0% |
| Sep 22 | William Blair | Downgrade | Outperform → Market Perform | — | $11.65 | $9.45 | -18.9% | -24.9% | -22.7% | +6.5% | -1.7% | -4.2% |
| Sep 10 | Cowen & Co. | Maintains | Market Perform → Perform | — | $15.23 | $14.92 | -2.0% | -1.8% | -1.7% | -4.4% | -0.6% | -0.9% |
| Aug 12 | Barclays | Upgrade | Equal Weight → Overweight | — | $16.02 | $16.44 | +2.6% | -0.7% | +0.6% | -0.3% | -2.9% | -3.6% |
| May 28 | Baird | Maintains | Outperform → Outperform | — | $21.00 | $22.13 | +5.4% | +1.9% | +2.3% | -4.0% | -0.4% | -2.5% |
| Mar 29 | Goldman Sachs | Maintains | Buy → Buy | — | $24.35 | $24.10 | -1.0% | -1.4% | +0.1% | +7.4% | -5.5% | -0.7% |
| Mar 29 | Citigroup | Maintains | Buy → Buy | — | $24.35 | $24.10 | -1.0% | -1.4% | +0.1% | +7.4% | -5.5% | -0.7% |
| Mar 29 | Barclays | Maintains | Equal Weight → Equal Weight | — | $24.35 | $24.10 | -1.0% | -1.4% | +0.1% | +7.4% | -5.5% | -0.7% |
| Mar 29 | Piper Sandler | Maintains | Overweight → Overweight | — | $24.35 | $24.10 | -1.0% | -1.4% | +0.1% | +7.4% | -5.5% | -0.7% |
| Mar 29 | William Blair | Maintains | Outperform → Outperform | — | $24.35 | $24.10 | -1.0% | -1.4% | +0.1% | +7.4% | -5.5% | -0.7% |
No insider trades available.
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
Unable to provide analysis as the filing summary lacks substantive disclosure details; investors should review the full 8-K filing on SEC.gov to understand what material information INNV disclosed.
Mar 17
8-K
InnovAge Holding Corp. -- 8-K Filing
InnovAge reported strong Q2 2026 results with improved operations, demonstrating successful execution of its PACE platform expansion strategy for dual-eligible seniors.
Feb 3
Data updated apr 25, 2026 3:42pm
· Source: massive.com